Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Liver Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03273608
What this trial is testing

Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients

Who this might be right for
Hepatocellular Carcinoma
Taipei Veterans General Hospital, Taiwan 120
Testing effectiveness (Phase 2)Looking for participantsNCT07105748
What this trial is testing

HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)

Who this might be right for
Mixed Hepatocellular-cholangiocarcinoma
Fudan University 45
Testing effectiveness (Phase 2)Ended earlyNCT00971126
What this trial is testing

Study of Sorafenib With Combination of Thalidomide in Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
National Health Research Institutes, Taiwan 3
Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Not applicableLooking for participantsNCT05263830
What this trial is testing

Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by Immunotherapy

Who this might be right for
Hepatocellular Carcinoma
Assistance Publique - Hôpitaux de Paris 240
Early research (Phase 1)Study completedNCT01497444
What this trial is testing

Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Kidney CancerLiver Cancer
Alliance for Clinical Trials in Oncology 24
Large-scale testing (Phase 3)UnknownNCT02240771
What this trial is testing

Transarterial Chemotherapy Compared With Oral Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
All India Institute of Medical Sciences 124
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05195294
What this trial is testing

Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaLiver Cancer, AdultLiver Cell Carcinoma
Lion TCR Pte. Ltd. 55
Early research (Phase 1)Study completedNCT00732836
What this trial is testing

Hepatic Arterial Infusion (HAI) of Abraxane

Who this might be right for
Liver CancerAdvanced CancersSolid Tumors
M.D. Anderson Cancer Center 64
Testing effectiveness (Phase 2)WithdrawnNCT06690281
What this trial is testing

A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CarcinomaPancreatic CancerHepatocellular Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01092091
What this trial is testing

Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)

Who this might be right for
NeoplasmHepatocellular Carcinoma
Bio-Cancer Treatment International Limited 20
Early research (Phase 1)Ended earlyNCT04116320
What this trial is testing

Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors

Who this might be right for
MelanomaBreast CancerMerkel Cell Carcinoma+10 more
Craig L Slingluff, Jr 5
Very early researchLooking for participantsNCT05098197
What this trial is testing

GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)

Who this might be right for
Advanced Liver CancersTumor Infiltrating LymphocyteTreatment Side Effects+2 more
Shanghai Juncell Therapeutics 50
Not applicableLooking for participantsNCT06641713
What this trial is testing

HAIC Compared With TACE in Huge Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatic ChemotherapyLiver Cancer
Sun Yat-sen University 664
Not applicableUnknownNCT06607120
What this trial is testing

Prognosis Stratification for Advanced HCC Receiving TACE with PD-1/PD-L1 Inhibitors and Molecular Target Therapies

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 950
Testing effectiveness (Phase 2)Study completedNCT00002608
What this trial is testing

Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors

Who this might be right for
Adrenocortical CarcinomaBrain and Central Nervous System TumorsHead and Neck Cancer+4 more
Ottawa Regional Cancer Centre 30
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT01687673
What this trial is testing

Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of California, San Francisco 29
Testing effectiveness (Phase 2)Study completedNCT02843802
What this trial is testing

Combination of Cryosurgery and NK Immunotherapy for Advanced Liver Cancer

Who this might be right for
Secondary Malignant Neoplasm of Liver
Fuda Cancer Hospital, Guangzhou 30
Next Page